Information, not a decision

Pancreatic cancer: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 15 Nov 2026

Open trials (1213)

NCT07488676	Phase 1/2	A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors	Recruiting
NCT07024615	Phase 1	A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer	Recruiting
NCT07360314	Phase 1	Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors	Recruiting
NCT07522073	Phase 3	A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting
NCT07644559	Phase 2	A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer	Recruiting
NCT04924075	Phase 2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting
NCT07458347	Phase 1	A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation	Recruiting
NCT01174121	Phase 2	Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer	Recruiting
NCT04907643	No phase	Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	Recruiting
NCT06914128	Phase 1/2	A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors	Recruiting
NCT07912593	Phase 1/2	A KRAS Inhibitor in Participants With Advanced Solid Tumors	Recruiting
NCT05053971	Phase 1/2	Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors	Recruiting

1201 more in the doctor's list on the site.

Phase 3 trials that ended in the last 90 days

No phase 3 trial in this list ended in the last 90 days.

Guidelines

ESMO Clinical Practice Guidelines
NCCN Guidelines
Pancreatic Adenocarcinoma, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review.
Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small-intestinal and pancreatic NETs.

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 15 Nov 2026

https://frontlightresearch.com/en/doctor/pancreatic-cancer/tumor-board